Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosisCarmen Herranz, Aslihan Ugun‐Klusek, José Antonio Rodríguez-Portal et al.|EMBO Molecular Medicine|2021Cited by 21
Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and TissueRoderic Espín, Miguel Ángel Pujana, Alexandra Baiges et al.|Molecular Cancer Research|2021Cited by 9
Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary functionXavier Farré, Miguel Ángel Pujana, Roderic Espín et al.|ERJ Open Research|2021Cited by 3
Supplementary Table 2 from Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and TissueRoderic Espín, Miguel Ángel Pujana, Alexandra Baiges et al.|Unknown|2023Cited by 0
Data from Heterogeneity and Cancer-Related Features in Lymphangioleiomyomatosis Cells and TissueRoderic Espín, Miguel Ángel Pujana, Alexandra Baiges et al.|Unknown|2023Cited by 0